CureVac - Stock Price History | CVAC

Historical daily share price chart and data for CureVac since 2022 adjusted for splits. The latest closing stock price for CureVac as of May 27, 2022 is 19.35.
  • The all-time high CureVac stock closing price was 136.27 on December 09, 2020.
  • The CureVac 52-week high stock price is 125.66, which is 549.4% above the current share price.
  • The CureVac 52-week low stock price is 14.20, which is 26.6% below the current share price.
  • The average CureVac stock price for the last 52 weeks is 40.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CureVac Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 73.9940 85.1000 127.5300 33.7200 34.3100 -57.68%
2020 69.4879 55.9000 136.2700 43.8000 81.0700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.621B $0.116B
CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.107B 9.86
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.761B 16.99
Biohaven Pharmaceutical Holding (BHVN) United States $10.111B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.648B 0.00
Emergent Biosolutions (EBS) United States $1.770B 7.57
Arcus Biosciences (RCUS) United States $1.376B 34.89
Myovant Sciences (MYOV) United Kingdom $1.033B 0.00
Zymeworks (ZYME) Canada $0.397B 0.00
Gelesis Holdings (GLS) United States $0.345B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.110B 22.60
SQZ Biotechnologies (SQZ) United States $0.100B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00